These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 32993646)

  • 1. Retention and outcomes for clients attending a methadone clinic in a resource-constrained setting: a mixed methods prospective cohort study in Imphal, Northeast India.
    Kermode M; Choudhurimayum RS; Rajkumar LS; Haregu T; Armstrong G
    Harm Reduct J; 2020 Sep; 17(1):68. PubMed ID: 32993646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A longitudinal comparison of retention in buprenorphine and methadone treatment for opioid dependence in New South Wales, Australia.
    Burns L; Gisev N; Larney S; Dobbins T; Gibson A; Kimber J; Larance B; Mattick RP; Butler T; Degenhardt L
    Addiction; 2015 Apr; 110(4):646-55. PubMed ID: 25516077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention and its predictors among methadone maintenance treatment clients in China: a six-year cohort study.
    Cao X; Wu Z; Rou K; Li L; Lin C; Wang C; Luo W; Pang L; Yin W; Li J;
    Drug Alcohol Depend; 2014 Dec; 145():87-93. PubMed ID: 25448082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment retention, drug use and social functioning outcomes in those receiving 3 months versus 1 month of supervised opioid maintenance treatment. Results from the Super C randomized controlled trial.
    Holland R; Maskrey V; Swift L; Notley C; Robinson A; Nagar J; Gale T; Kouimtsidis C
    Addiction; 2014 Apr; 109(4):596-607. PubMed ID: 24304349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial.
    Hser YI; Saxon AJ; Huang D; Hasson A; Thomas C; Hillhouse M; Jacobs P; Teruya C; McLaughlin P; Wiest K; Cohen A; Ling W
    Addiction; 2014 Jan; 109(1):79-87. PubMed ID: 23961726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of community-based extension clinics of methadone maintenance therapy for opiate-dependent clients: A prospective cohort study in Dehong Prefecture, Yunnan Province of China.
    Zhang G; Yang Y; Ye R; Zhang D; Shan D; Hu Y; Dai B; Liu Z
    Medicine (Baltimore); 2018 Nov; 97(47):e13323. PubMed ID: 30461647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom.
    Hickman M; Steer C; Tilling K; Lim AG; Marsden J; Millar T; Strang J; Telfer M; Vickerman P; Macleod J
    Addiction; 2018 Aug; 113(8):1461-1476. PubMed ID: 29672985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methadone, buprenorphine and preferences for opioid agonist treatment: A qualitative analysis.
    Yarborough BJ; Stumbo SP; McCarty D; Mertens J; Weisner C; Green CA
    Drug Alcohol Depend; 2016 Mar; 160():112-8. PubMed ID: 26796596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Perceptions of extended-release naltrexone, methadone, and buprenorphine treatments following release from jail.
    Velasquez M; Flannery M; Badolato R; Vittitow A; McDonald RD; Tofighi B; Garment AR; Giftos J; Lee JD
    Addict Sci Clin Pract; 2019 Oct; 14(1):37. PubMed ID: 31570100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Readiness and recovery: Transferring between methadone and buprenorphine/naloxone for the treatment of opioid use disorder.
    Bishop B; Gilmour J; Deering D
    Int J Ment Health Nurs; 2019 Feb; 28(1):226-236. PubMed ID: 30019812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
    Richert T; Johnson B
    Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of heroin abstinence in opiate substitution therapy in heroin-only users and dual users of heroin and crack.
    Heidebrecht F; MacLeod MB; Dawkins L
    Addict Behav; 2018 Feb; 77():210-216. PubMed ID: 29065377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retention in Georgia opioid substitution therapy program and associated factors.
    Ruadze E; Todadze K
    Harm Reduct J; 2016 Dec; 13(1):35. PubMed ID: 27931232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methadone and buprenorphine-naloxone are effective in reducing illicit buprenorphine and other opioid use, and reducing HIV risk behavior--outcomes of a randomized trial.
    Otiashvili D; Piralishvili G; Sikharulidze Z; Kamkamidze G; Poole S; Woody GE
    Drug Alcohol Depend; 2013 Dec; 133(2):376-82. PubMed ID: 23916321
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of state opioid substitution treatment program in Georgia.
    Piralishvili G; Chavchanidze M; Gamkrelidze I; Nikolaishvili N
    Georgian Med News; 2014 Apr; (229):62-6. PubMed ID: 24850608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-Year Outcome of Opioid Maintenance Treatment in Heroin-Dependent Patients: Results from a Naturalistic Study in a Nationally Representative Sample.
    Soyka M; Strehle J; Rehm J; Bühringer G; Wittchen HU
    Eur Addict Res; 2017; 23(2):97-105. PubMed ID: 28376505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-month retention and changes in quality of life and substance use from a low-threshold methadone maintenance therapy programme in Durban, South Africa.
    Scheibe A; Shelly S; Gerardy T; von Homeyer Z; Schneider A; Padayachee K; Naidoo SB; Mtshweni K; Matau A; Hausler H; Marks M
    Addict Sci Clin Pract; 2020 Feb; 15(1):13. PubMed ID: 32085807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High retention in an opioid agonist therapy project in Durban, South Africa: the role of best practice and social cohesion.
    Marks M; Scheibe A; Shelly S
    Harm Reduct J; 2020 Apr; 17(1):25. PubMed ID: 32295595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study.
    Kenworthy J; Yi Y; Wright A; Brown J; Maria Madrigal A; Dunlop WCN
    J Med Econ; 2017 Jul; 20(7):740-748. PubMed ID: 28489467
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Buprenorphine versus methadone for opioid dependence: predictor variables for treatment outcome.
    Gerra G; Borella F; Zaimovic A; Moi G; Bussandri M; Bubici C; Bertacca S
    Drug Alcohol Depend; 2004 Jul; 75(1):37-45. PubMed ID: 15225887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.